<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 300 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page299.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=300">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 300 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 300</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=300"><img src="../thumb/300.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Anti-Microbials - 18.12                                                        2020-04 / 263
       (S4) TABS, 42/20.2.8/0026     Special precautions: Safety & effic not est with hepatit.B (HBV)   ren.impairm., safety & effic. not est.in HBV & HIV co-infects., con-
       710019-001: 600 mg, 30, R209,06  co-infect., monit.hepat.funct.for sev. mnths.in co-infect.HBV pts.who   com. lamivudine/meds.contain.lamivudine in combinat., concom.
       Dosage: Admin.in combinat.with a protease inhibit. and/or   have discont. ther., obesity & prolong.nucleoside use poss.risk fact.  St Johns Wort not recomm., safety & effic.in pts.less than 18 yrs.
       nucleoside analog.reverse transcript. inhibit. Admin.on empty   for lact.acidos., liv.dis.risk fact., discont.if find. suggest. lact.acidos./  not est., concom. atazanavir/ saquinavir not recomm., pregn., lac-
                     st
       stomach. Consid.bedt.dos.dur.1  2-4 wks ther.& in pts. exper.   hepatotoxic., imp.ren.funct., concom./rec.nephrotox.meds., adjust.  tat., sev.hepat.impairm/prev.liv.injury hist, fail.with efavirenz con-
       neurologic.effs.              dos.interv.if creatinine clear.&lt;50 ml/min., test for hepatit.B bef. init.  tain.antiretrov.treatm.
       Adults: Recomm.dos.: 600 mg once dly. Adolesc. & childr.(17   ther., discont.concom.didanosine if didanosine advers. effs.develop,   Side effects: Lactic.acidos.& sev.hepatomegaly with steatos.incl.
       yrs.& und): 600 mg at bedt. Use only in adults & childr.weigh.great.  recom.concom.atazanavir be admin. with ritonavir, Ca & vit.D sup-  fatal.esp.in women, sev.ac. exacerbat. of hepatit.B aft.discontinuat.
       than or equal to 40 kg        plementat. poss benefic., elderly, cont.lact.  of emtricitabine/ tenofovir, ser.CNS & psych. sympts., poss.birth de-
       Contraindications: Concom.terfenadine/ astemizole /cisapride/  Drug interactions: Ser.conc.of drugs elimin.by act.tubul.secret.may   fects, pancreatit., rais.ser. cholestrol & triglycer.conc., sev.depress.,
       midazolam/triazolam/ergot derivat.as ser./life threat.adverse effs.  incr., ser.conc.incr.by agents decr.ren.funct., C max & AUC of didanosine   suicid. ideat./ attempts, amnes., aggress., mania, tinnit., palpitat.,
       poss., pregn. & lactat., childr.less than 3 yrs./weigh. &lt;13 kg, concom.   incr., AUC & C min of atazanavir decr.  dyspn., GI disturbs., rais.liv.enzym., hepat. fail., rash, prurit., erythem.
       prev.liv.injury hist.with efavirenz contain.ART.           multiforme/nail disords./Stev.-John.syndr., photo allerg. dermatit.,
       Side effects: Redistribut./accumulat.of body fat, CNS effs., abnorm.  ATAZOR, Emcure [P/S]  skin discol., arthralg., myalg., myopathy, fatig., asthen., pneum.,
       co-ordinat., abnorm.dreams, vertigo, convuls., paraesthes., periph.  Atazanavir sulph.  neutropen., anaem., hyperbilirubinaem., abnorm.dreams, head-
       neuropathy, GI disturbs., malabsorpt., hepat.fail., myopathy, skin rash/  Indications: In combinat.with other anti-retrovir. agents for HIV-1   ache, asthen., dizzin., insom., anx., paraesthes., periph. neuropathy,
       incr.swell./erythema multiforme & Stev. John.syndr., nail disords., skin   infect.in antiretrov.naïve/treatm. exper. pts.  rhinit., pain, hypophosphataem., bone pain, osteomalac., nephrit.,
       discolourat., alcoh. intol., allerg. reacts., asthen., hot flush., flu-like   (S4) CAPS, 43/20.2.8/236, 46/20.2.8/0682  nephrogen.diabet. insipid., ren.proxim.tubul.eff.incl.Fanconi syndr.&
       sympts., malaise, pain, syncope, aggrav.depress., anx., confus., emot.  716209-001: 200 mg, 60, R456,47  ac.tubul.necros., ac.ren.fail., sinusit., URTI, nasopharangit., immune
       labilit., impot., libido chang., speech disords., trem., tinnit., abnorm.  718217-001: 300 mg, 30, R380,67  reconstitut.syndr., immune-allerg.liv.injury/fail., Cushingoid appear.,
       vis., taste pervers., flush., palpitat., tachycard., hepatit., weight gain/   Dosage: 400 mg once dly.with food.  redistribut./accumulat.of body fat, hyperglyceridaem., insul.resist.,
       loss, arthralg./myalg., asthma, sinusit., URTI, acne, alopec., eczema,   Concom.ritonavir: 300 mg once dly.with ritonavir 100 mg once   breast enlargem., periph.& fac.wast., hyperton., myosit., rhabdomy-
       folliculit., seborrhea., skin exfoliat., urticar., rais.ser. cholester.& tri-  dly. Treatm.without ritonavir not recomm. for treatm.-exper.pts.  olys., osteonecros., reduc.bone density.
       glycerid. conc., incr.tot.cholester.  with prior virolog. fail.  Special precautions: Monit.hepat.funct.for sev. mnths. in pts.
       Special precautions: Must not be used as monother. /add.on as   Concom.efavirenz: Treatm.naïve pts: 300 mg & ritonavir 100 mg   co-infect.with HIV & HBV who discont. ther.& appropr.init.of anti-
       sole agent to fail.regim., consid. alternat.to clarithromycin, use bar-  with efavirenz 600 mg all once dly. Do not co-admin.without ritonavir.   hepatit.B ther. poss.necess., obesity & prolong.nucleoside use poss.
       rier contracept.in combinat.with other methods, teratogenic.report.,   Dos. recommendat.in treatm.-exper.pts.with prior virolog. fail.not est.  risk fact.for lact.acidos., liv.dis.risk fact., discont. if find.suggest.lact.
       pregn.test in women of childbear.potent.bef.init.ther., pass.into breast   Concom.tenofovir: 300 mg & ritonavir 100 mg with tenofovir 300   acidos./hepatotoxic., test for chron.hepatit.B bef.init.ther., reg.monit.
       milk, ref.to prod.lit.when prescrib.other meds., consid.simultan.dis-  mg all as sngl.dly.dos.with food. Do not co-admin.without ritonavir.  for jaund.(lab.bilirub.& liv.enzym) & bleed.tendenc., immed.discont
       cont.of all antiretrovir.meds.if combinat.regim.is interrupt.because of   Admin.2 hrs.bef.& 10 hrs. aft.H 2-recept.antagon.  treatm./meds contain.efavirenz & monit.pts.for liv.fail.for up to 12
       suspect. intol.& restart medicat.at same time upon resolut. of intol.  Contraindications: Concom. CYP3A4 substrats. with narrow   mnths., not recomm.in mod.to sev.hepat.impairm., treatm. discont.
       sympts., intermitt.monother./sequent. reintroduct. not advis., discont.  therap.wind. eg. astemizole/ terfenadine/ cisapride/pimozide/qui-  poss.reqd.if ser.psych.sympt.exper., determ. creatin.clear.bef.init.&
       in sev.rash, consid. prophylax. with appropr.anthistam./corticoster.  nidine/ bepridil/ triazolam/oral midazolam & ergot alkaloids, mod.  dur.ther., ren.funct. monit.in pts.at risk/hist.of ren.dysfunct., avoid
       for mild to mod.rash to improv.tol.& resolv.rash, nerv. syst.& psych.  to sev. hepat.impairm., concom. indinavir/St John’s Wort/ flutica-  with concom./rec.nephrotox.agents, elderly, rash report. with efa-
       sympts.report., be alert to psychos.-like reacts.& sev.ac.depress.incl.  sone propion./ HMG CoA reduct.inhibits.not recomm., concom.   virenz & clarithromycin theref.consid.alt., poss.incr. didanosine-relat.
       suicid.ideat./ attempts.report., ment.illn./subst.abuse hist., chron. liv.  voriconazole/rifampicin with low dose ritonavir, safety in pregn.&   adverse eff., high.freq. adverse events with efavirenz/ritonavir,
       dis., monit.liv.enzymes partic.in known/ suspect.hepatit.B/C infect.  lactat.not est., combinat.treatm. with ritonavir not stud.in hepat.  monit. liv. enzym.with efavirenz/ritonavir, do not admin. concom.
                                     impairm.& not recomm.
       hist./concom.hepatotox meds., cholestrol.monit., use not assess.in   saquinavir as sole protease inhibit., reg. carbamazepine lev.monit.
       paed. pts. bel.3 yrs./weigh.&lt;13 kg, lact.intol.  Side effects: Headache, jaund., scleral icterus, abdom.pain, GI dis-  with concom.use,altern. anticonvuls.agent advis., Ca chann.blocks.
       Drug interactions: Plasma conc.of other compds. that are CY-  turbs., periph.neurolog.sympts., fev., myalg., asthen., fatig., allerg.  dos. adjustm.guid.by clinic. respons., women of child-bear.potent.
       P3A4 substrat.poss.decr., AUC & C trough of indinavir decr., saquinavir   reacts., weight decr./-gain, psych.disords., CNS effs., hypertens.,   should undergo pregn.test.bef.init. ther., barr.contracept.tog.with
       & clarithromycin AUC & C max decr., incr. freq. of S/E with ritonavir,   syncope, oed., palpitat., dyspn., pancreatit., hepatit., hepatosple-  other methods recomm., pt.on treatm.may devel.opportunist. infect./
       rifampicin decr.AUC & C max ,, methadone plasma lev.decr.result.in   nomeg., alopec., eczema, prurit., urticar., vasodilat., arthralg., musc.   other HIV infect.compl., contin.approp. precaut.prevent.HIV trans-
       opiate withdr.signs in HIV infect. IV drug users, expect.reduc.conc.  atrophy, myopathy, urin.disords., kidn.pain, nephrolithias., gynaeco-  miss.risk, investig. child.expos.in utero to nucleoside & nucleotide
       with St John’s Wort           mast., chest pain, lipodystrophy, hyperbilirubinaem., hyperglycaem.,   analog.for poss.mitochondr.dysfunct.in case of relev.S&S, safety &
                                     diab.mellit., diab.ketoacidos., rhabdomyolys., anaphylax., bld. dys-
       ASPEN LAMZID, (Aspen Pharmacare:    cras., PR interv.prolongat.  effic.in pts.with both HIV & hepatit.B not est., liv.enzym.monit.in pts.
       Pharma) Pharmacare [P/S]      Special precautions: Admin.concom.didanosine 2 hrs.aft.Ataza-  with mild to mod.liv.dis & chron.hepatit.B or C, seiz/psych. disord.
       Zidovudine 300 mg, lamivudine 150 mg  navir, monit.for tenofovir assoc. adverse effs.with concom.ther.,   hist., discont.ther.with sev.skin rash assoc. with blister./desquamat./
       Indications: HIV infect.when combinat.ther.of zidovud. & lami-  recomm.dos.with saquinavir combinat.not est., monit.INR with   mucos.involvem.& fev., monit.ser.lipids & bld.gluc., bone monit.with
       vud.reqd.                     concom. warfar., ECG monit.recomm.with concom. Ca chann.block.  bone fract. hist./risk of osteopen.
       (S4) TABS, 38/20.2.8/0112     (diltiazem), admin.2 hrs.bef./1 hr. aft. concom.antacids/buffer.meds.,   Drug interactions: Reduc.NNRTI conc.with St John’s Wort expect.,
       703627-001: 60, R389,60       ketoconazole & itraconazole dos.&gt;200 mg/day when combin.with   addit.CNS effs.with alcoh./ psychoact.meds., alt.plasma conc.of
       Dosage: As a fix.dos.combinat.do not prescrib. when dos.ad-  ritonavir, alt.non-hormon.contracept.with ritonavir combinat.ther.,   meds.prim. metab.by cytochrome P450 isoenzym., rifampicin decr.
       justm.necess.                 PDE 5 assoc.adverse events poss. incr., mild to mod.hepat.impairm.,   efavirenz conc., clarithromyc.plasma lev. decr., efavirenz reduc.vori-
       Adults & childr.over 12yrs: 1 tab. 2xdly.  eval.for alternat. etiolog.in pts.with simultan. hyperbilirubinaem.   conazole plasma conc.& vice versa, amprenavir./fosamprenavir/
       Contraindications: Abnorm.low neutrophil counts /haemoglo-  with hepat.transamin.elev., elderly, discont.if sev. rash/nephrolithi-  atazanavir/ indinavir/lopinavir & saquinavir ser.conc decr., efavirenz
       bin lev., safety in pregn.not est., lactat., safety & effic.in childr.  as.develops, incr.risk for furth. transamin.elev.in underly.hepatit.B/C   metabol.inhibit.by grapefruit juice, conc.of drugs reduc.ren.funct./
       und.12 yrs.not est.,          or mark. transamin.elev.prior to init.treatm., resist.does not preclud.  elimin.by act. tubul.secret.may be incr., atazanavir & lopinavir/ ri-
       Side effects: Bld.dyscras., lact.acidos.in absenc. of hypoxaem.  the use of other protease inhibit., poss. incr. bleed.by haemophiliacs,   tonavir incr.tenofovir conc., reduc.anticonvuls. &/efavirenz.plasma
       usually assoc.with sev hepatomegaly & steatos., GI disturbs., my-  immune reconstit. syndr. where pts. whose immune syst.responds   lev.with carbamazepine/ phenytoin & phenobarbit., sertraline conc.
       alg., myopathy, CNS effs. incl.convuls., dyspn., cough, nail & skin   may develop inflamm.respon.to indol./ resid. opportunist. infects.ne-  decr., HMG-CoA reduct.inhibit./indinavir/itraconazole conc.decr.,
       pigmentat., rash, sweat., urticar., prurit., urin. freq., chest & gen.  cessitat.furth.evaluat. & treatm., pre-exist.conduct.syst.dis., meds.  potent.decr.ketoconazole conc., rifabutin conc.decr., plasma conc.
       pain, chills, flu-like syndr., asthen., gynaecomast., nas.sympts., mus-  known to induc.PR-interv. prolongat., new onset/exacerbat. of exist.  of other compds. that are CYP3A4 substrat.poss.decr., poss.Ca
       culoskelet. pain, pancreatit., periph. neuropathy/exacerbat.thereof,   diab. mellit., hyperglycaem.  chan. block.conc.decr., decr. methadone plasma conc.& poss.opi-
       hypersens.reacts., hair loss.  Drug interactions: Plasma conc.decr.by other meds.that induc   ate withdr.signs with efavirenz, ethinyl oestrad.conc.incr., plasma
       Special precautions: Poss.contin.of HIV complicat. & opportunist   CYP3A activ.(e.g. rifampicin), drugs inhibit. CYP3A incr.plasma   conc.of warfar.potent. incr./decr.
       infects., risk of illn. assoc. with immune suppress., discont. use if pan-  conc., CYP3A-mediat.interact.poss.change when co-admin.with   ATRESLAWIN, Zentiva [P/S]
       creat. suspect., monit.haematolog.paramet., pts.esp. obese women   ritonavir a potent CYP3A inhibit., plasma conc. reduc.by St John’s   Efavirenz 600 mg, emtricitabine 200 mg, tenofovir disoproxil fu-
       with hepatomegaly/ hepatit./other risk fact.for liv.dis., concom self-  wort, irinotecan metabol. interfer. with incr.it’s toxicit., theophyll.  marate 300 mg.
       admin.medicat., ren./ hepat.impairm., incr.incid.of neutropen.in pre-  plasma conc. reduc., didanosine/efavirenz decr.expos.to Ataza-
       exist.neutropen./anaem./low Vit B 12 lev.& concom. paracet., elderly,   navir, tenofovir conc.incr., incr.expos.to other protease inhibit.with   Indications: HIV-1 infect.treatm.in adults alone as complete regi-
                                                                  men or in combinat.with other anti-retrovir.
       disc..if aminotransferase lev.are rapidly elevat.  Atazanavir+ritonavir co-admin., incr.saquinavir conc., hyperbilirubi-
       Drug interactions: Poss.incr.toxic.risk with potent nephrotox./my-  naem. assoc.with indinavir, amiodarone/bepridil/syst. lidocaine &   (S4) TABS, 47/20.2.8/0035
                                                                  718925-001: 30, R606,63
       elosuppres.meds, clear.of meds. metabol.by hepat.glucuronidat.&   quinidine conc.incr., expos.to wafar./ TCA’s incr.with potent.to prod.  Dosage: Adults: 1 tab.once dly.on empty stomach. Bedt.dos.may
       Aspen Lamzid decr., plasma conc.of phenytoin incr./decr., incr.risk   ser./life threat. events, plasma conc.reduc.by anticonvuls., Ca chann.   improv.CNS sympt. tolerabil.
       of neutropen.with NSAID’s & paracet., incr. in vitro antagonist.ac-  block.plasma conc.incr., incr.expos.to clarithromyc. (macrolide anti-  Contraindications: Concur.astemizole/bepridil/ cisapride/ mida-
       tiv with other nucleoside analog.incl.ribavirin/stavudine, trimetho-  biot.) & poss.QTc prolongat., plasma conc.of fluticasone incr.with   zolam/pimozide/triazolam/ergot derivat.& voriconazole, mod-sev.
       prim incr. plasma lev.        Atazanavir alone, ser.cortisol conc.decr.with concom. fluticasone &   ren.impairm., safety & effic.not est.in HBV & HIV co-infects., con-
       ASPEN TENOFOVIR, (Aspen Pharmacare: Pharma)    Atazanavir & ritonavir combinat., myopathy incl.rhabdomyolys.with   com. lamivudine/meds.contain.lamivudine in combinat., concom.
                                     HMG CoA reduct.inhibit, plasma conc.decr.by H 2-recept. antagon.&
       Pharmacare [P/S]              proton pump inhibit., immunosuppress. /ketoconaz.& itraconazole   St Johns Wort not recomm., safety & effic.in pts.less than 18 yrs.
       Tenofovir disoproxil fumarate  plasma conc.incr., voriconazole alone poss.incr.plasma conc., ethinyl   not est., concom. atazanavir/saquinavir not recomm., pregn., lac-
       Indications: In combinat.with other antiretrovir.in adults with HIV-1.  estradiol & norethindrone lev.reduc., PDE 5 inhibit. conc.incr., rifabu-  tat., sev.hepat.impairm.
       (S4) TABS, 43/20.2.8/0181     tin/trazodone plasma conc.incr.  Side effects: Lactic.acidos.& sev.hepatomegaly with steatos.incl.
       715056-001: 300 mg, 30, R309,35                            fatal.esp.in women, sev.ac. exacerbat. of hepatit.B aft.discont.of
       Dosage: 300 mg once dly.without regard to food.  ATENEF, Sonke [P/S]  emtricitabine / tenofovir, ser.CNS & psych.sympts., poss.birth de-
       Contraindications: Uncontrol.ren.fail., pregn. & lactat., safety &   Efavirenz 600 mg, emtricitabine 200 mg, tenofovir disoproxil fu-  fects, pancreatit., rais.ser.cholestrol & triglycer. conc., sev.depress.,
       effic.in childr.und.18 yrs.not est.  marate 300 mg.        euphor., depersonalisat., suicid. ideat./attempts, amnes., aggress.,
       Side effects: Lactic.acidos.& sev.hepatomegaly with steatos.incl.  Indications: HIV-1 infect.treatm.in adults alone as complete regi-  paranoia, hallucinat., agitat., mania, confus., somnol., tinnit., palpi-
       fatal., sev.ac.exacerbat.of hepatit. B aft.discontinuat., ren.impairm.  men or in combinat.with other anti-retrovir.  tat., dyspn., GI disturbs., rais. liv. enzym.,incr.ser.lipas./pancreat.amyl-
       incl.ac. ren. fail., mild to mod.GI effs., dizzin., headache, pain, fev.,   (S4) TABS, 47/20.2.8/0483  ase., elev. creat.kinase, hepat.fail., rash, prurit., erythem. multiforme/
       abdom./back/chest pain, asthen., lipodystrophy, arthralg., myalg.,   720428-002: 30, R238,04  nail disords./Stev.-John.syndr., photo allerg. dermatit., skin discolor.,
       depress., insomn., periph.neuropathy, anx., pneumon., rash, sweat.,   Dosage: Adults: 1 tab.once dly.on empty stomach. Bedt.dos.may   nail disords., urticar., hyperhydros., arthralg., myalg., myopathy, fatig.,
       weight loss, allerg.reacts., hypophosphataem., dyspn., pancreatit.,   improv.CNS sympt. tolerabil.  asthen., pneum., neutropen., anaem., hyperbilirubinaem., abnorm.
       hepatit., ren.insuffic./-fail., BMD decr.from baseline, inflamm.respons.  Contraindications: Concur.astemizole/ bepridil/ cisapride/ mida-  dreams/think., headache, asthen., dizzin., insom., anx., imp. concen-
       to indolent/resid.infects.necessit.furth.eval.& treatm.  zolam/pimozide/triazolam/ergot derivat.& voriconazole, mod-sev.  trat., convuls., paraesthes., periph. neuropathy, trem., abnorm co-</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page299.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page295.html">295</a>&nbsp;&nbsp;&nbsp;<a href="page296.html">296</a>&nbsp;&nbsp;&nbsp;<a href="page297.html">297</a>&nbsp;&nbsp;&nbsp;<a href="page298.html">298</a>&nbsp;&nbsp;&nbsp;<a href="page299.html">299</a>&nbsp;&nbsp;&nbsp;<a href="page300.html">300</a>&nbsp;&nbsp;&nbsp;<a href="page301.html">301</a>&nbsp;&nbsp;&nbsp;<a href="page302.html">302</a>&nbsp;&nbsp;&nbsp;<a href="page303.html">303</a>&nbsp;&nbsp;&nbsp;<a href="page304.html">304</a>&nbsp;&nbsp;&nbsp;<a href="page305.html">305</a>
             </td>
             <td width="35%"><a href="page301.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page301.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
